Showing results (1761-1770 of 1,815) with videos related to
Sort By:
Pageof 182
Circulation. Cardiovascular Interventions|January 10, 2016
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled AnalysisGennaro Giustino, Usman Baber, Olga Salianski, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patientsMarie Jachiet, Béatrice Flageul, Alban Deroux, et al.JACC. Cardiovascular Interventions|June 24, 2017
6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel)Romain Didier, Marie Claude Morice, Paul Barragan, et al.The New England Journal of Medicine|September 29, 2019
Five-Year Outcomes after PCI or CABG for Left Main Coronary DiseaseGregg W Stone, A Pieter Kappetein, Joseph F Sabik, et al.Journal of the American Academy of Dermatology|July 21, 2010
Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009Vinzenz Oji, Gianluca Tadini, Masashi Akiyama, et al.Journal of the American Academy of Dermatology|March 3, 2019
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohortSarah Faiz, Jonathan Giovannelli, Céline Podevin, et al.Journal of the American College of Cardiology|December 3, 2014
6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trialMartine Gilard, Paul Barragan, Arif A L Noryani, et al.Bulletin Du Cancer|February 6, 2018
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.European Journal of Cancer (Oxford, England : 1990)|June 7, 2019
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancersChristine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.Intensive Care Medicine|October 26, 2022
ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically ill children- a systematic review and meta-analysisDavid W Brossier, Lyvonne N Tume, Anais R Briant, et al.Pageof 182